Skip to main content
Clinical Trials/NCT01493063
NCT01493063
Active, not recruiting
Not Applicable

BRD/11/02-Y "LACTACOL 01 - Impact of Breast Milk on the Neurodevelopment of Preterm Newborns".

Nantes University Hospital1 site in 1 country160 target enrollmentOctober 25, 2011

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Prematurity of Fetus
Sponsor
Nantes University Hospital
Enrollment
160
Locations
1
Primary Endpoint
To assess the impact of the protein content of human milk on the neuro-motor development of the preterm infant at 2 years of age
Status
Active, not recruiting
Last Updated
2 years ago

Overview

Brief Summary

The aim of the study is to estimate the impact of the protein content of breastmilk at the end of hospitalization of the preterm newborn, on the neurodevelopment at 2 years old.

The investigators expect a difference of at least 5 points of Development Quotient (DQ) when comparing extreme terciles of the protein content of breastmilk at the end of hospitalization.

Registry
clinicaltrials.gov
Start Date
October 25, 2011
End Date
September 2025
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Maternal decision of breastfeeding
  • Born between 28 and 34 weeks of amenorrhea
  • No important congenital pathology except prematurity
  • Efficiency of the breastfeeding compatible with the research by the investigator
  • Information and authorization of the parents or the parental authority

Exclusion Criteria

  • Maternal decision of not breastfeeding
  • Born before 28 weeks of amenorrhoea or after or at 34 weeks of amenorrhoea
  • Important congenital pathology
  • Efficiency of the breastfeeding incompatible with the research by the investigator
  • Opposition from parents or the parental authority to participate to the research study

Outcomes

Primary Outcomes

To assess the impact of the protein content of human milk on the neuro-motor development of the preterm infant at 2 years of age

Time Frame: At 2 years of age

ASQ (Ages and Stages Questionnaires) score at 2 years of age. The calculation of the sample size is only based on this endpoint. We wish to highlight a difference of at least 25 points of the ASQ score between both extreme terciles of protein concentration determined in breast milk at the end of hospitalization, when breastfeeding is exclusive (last sample of breastmilk before the end of hospitalization).

Secondary Outcomes

  • To assess the impact of the protein content of human milk on the coginitive intelligence of the preterm infant(At 7-8 years of age)
  • To assess the impact of the protein content of human milk on the executive functioning of the preterm infant(At 7-8 years of age)
  • To assess the impact of the protein content of human milk on the executive dysfunction of the preterm infant(At 7-8 years of age)
  • To assess the impact of the protein content of human milk on the child's behaviour in the classroom of the preterm infant(At 7-8 years of age)
  • To assess the impact of the protein content of human milk on the generalist clinical evaluation of the preterm infant(At 7-8 years of age)
  • To assess the impact of the protein content of human milk on the physical activity of the preterm infant(At 7-8 years of age)
  • To assess the impact of the protein content of human milk on the Body composition (% fat/lean mass)(At 2 years of age and at 7-8 years of age)
  • To assess the impact of the protein content of human milk on feeding behavior(At 2 years of age and at 7-8 years of age)
  • To assess the impact of the protein content of human milk on growth trajectory and metabolic status of the preterm infant(At 2 years of age and at 7-8 years of age)

Study Sites (1)

Loading locations...

Similar Trials